Stuart Jones

673 total citations
16 papers, 424 citations indexed

About

Stuart Jones is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Stuart Jones has authored 16 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Stuart Jones's work include Synthesis and Biological Evaluation (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Synthetic Organic Chemistry Methods (2 papers). Stuart Jones is often cited by papers focused on Synthesis and Biological Evaluation (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Synthetic Organic Chemistry Methods (2 papers). Stuart Jones collaborates with scholars based in United Kingdom and United States. Stuart Jones's co-authors include Julian M.C. Golec, Bohdan Waszkowycz, Richard J. K. Taylor, Donald Ogilvie, Ian D. Waddell, Allan M. Jordan, Emma Fairweather, James R. Hitchin, Dominic I. James and Helen Small and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Organic Letters.

In The Last Decade

Stuart Jones

16 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Jones United Kingdom 12 220 172 141 55 37 16 424
Carolyn A. Weigelt United States 14 255 1.2× 147 0.9× 169 1.2× 41 0.7× 53 1.4× 25 520
Roberta Tesch Germany 14 263 1.2× 217 1.3× 76 0.5× 63 1.1× 28 0.8× 20 520
E. Hampton Sessions United States 16 295 1.3× 240 1.4× 117 0.8× 42 0.8× 56 1.5× 20 635
M. Sabat United States 16 249 1.1× 354 2.1× 86 0.6× 63 1.1× 33 0.9× 32 621
Terrence L. Smalley United States 12 224 1.0× 263 1.5× 79 0.6× 32 0.6× 15 0.4× 20 551
Stuart C. Wilson United Kingdom 10 305 1.4× 208 1.2× 147 1.0× 19 0.3× 16 0.4× 14 555
J. Adam Willardsen United States 13 270 1.2× 479 2.8× 78 0.6× 31 0.6× 23 0.6× 22 712
John G. Catalano United States 12 236 1.1× 175 1.0× 81 0.6× 22 0.4× 34 0.9× 17 413
Tsung‐Chih Chen Taiwan 16 328 1.5× 219 1.3× 133 0.9× 25 0.5× 23 0.6× 27 550
Frank Kerrigan United Kingdom 8 429 1.9× 220 1.3× 465 3.3× 32 0.6× 79 2.1× 11 766

Countries citing papers authored by Stuart Jones

Since Specialization
Citations

This map shows the geographic impact of Stuart Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Jones more than expected).

Fields of papers citing papers by Stuart Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Jones. The network helps show where Stuart Jones may publish in the future.

Co-authorship network of co-authors of Stuart Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Jones. A scholar is included among the top collaborators of Stuart Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Jones. Stuart Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Newton, Rebecca, Bohdan Waszkowycz, Mark W. Richards, et al.. (2020). Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase. ACS Medicinal Chemistry Letters. 11(4). 497–505. 12 indexed citations
2.
Jones, Stuart, et al.. (2019). Synthesis of carbon‐14–labelled peptides. Journal of Labelled Compounds and Radiopharmaceuticals. 62(11). 713–717. 6 indexed citations
3.
Waszkowycz, Bohdan, Kate M. Smith, Alison E. McGonagle, et al.. (2018). Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides. Journal of Medicinal Chemistry. 61(23). 10767–10792. 26 indexed citations
4.
James, Dominic I., Kate M. Smith, Allan M. Jordan, et al.. (2016). First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib. ACS Chemical Biology. 11(11). 3179–3190. 94 indexed citations
5.
Hamilton, Niall M., Martin D. Dawson, Emma Fairweather, et al.. (2012). Novel Steroid Inhibitors of Glucose 6-Phosphate Dehydrogenase. Journal of Medicinal Chemistry. 55(9). 4431–4445. 53 indexed citations
6.
Doveston, Richard G., René R. E. Steendam, Stuart Jones, & Richard J. K. Taylor. (2012). Total Synthesis of an Oxepine Natural Product, (±)-Janoxepin. Organic Letters. 14(4). 1122–1125. 36 indexed citations
7.
Kitson, Sean L., et al.. (2010). Carbon‐14 radiosynthesis of 4‐(5‐chloro‐2‐hydroxyphenyl)‐3‐(2‐hydroxyethyl)‐6‐(trifluoromethyl)‐[4‐14C]quinolin‐2(1H)‐one (XEN‐D0401), A novel BK channel activator. Journal of Labelled Compounds and Radiopharmaceuticals. 53(3). 140–146. 5 indexed citations
8.
Laphookhieo, Surat, Stuart Jones, Steven A. Raw, Yolanda Sáinz, & Richard J. K. Taylor. (2006). Tandem oxidation processes for the regioselective preparation of 5-substituted and 6-substituted 1,2,4-triazines. Tetrahedron Letters. 47(23). 3865–3870. 19 indexed citations
9.
Sheehan, Scott M., John J. Masters, Michael R. Wiley, et al.. (2003). A four component coupling strategy for the synthesis of d-phenylglycinamide-derived non-covalent factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(14). 2255–2259. 18 indexed citations
10.
Liebeschuetz, John W., Stuart Jones, Christopher W. Murray, et al.. (2002). PRO_SELECT:  Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors. Journal of Medicinal Chemistry. 45(6). 1221–1232. 66 indexed citations
11.
Jones, Stuart, John W. Liebeschuetz, Christopher W. Murray, et al.. (2001). The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor Xa. Bioorganic & Medicinal Chemistry Letters. 11(5). 733–736. 20 indexed citations
12.
Golec, Julian M.C., Michael D. Mullican, Mark A. Murcko, et al.. (1997). Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme. Bioorganic & Medicinal Chemistry Letters. 7(17). 2181–2186. 20 indexed citations
13.
Batchelor, Mark, Roger J. Gillespie, Julian M.C. Golec, et al.. (1994). Total syntheses of close analogues of the immunosuppressant FK506. Tetrahedron. 50(3). 809–826. 17 indexed citations
14.
Golec, Julian M.C. & Stuart Jones. (1993). The synthesis of a C1-C8 lactone fragment of discodermolide. Tetrahedron Letters. 34(50). 8159–8162. 23 indexed citations
15.
Jones, Stuart, et al.. (1990). Preparation and chemistry of some 1,5-diphenyl-1λ4,2,4-thiadiazine 1-oxides. Journal of the Chemical Society Perkin Transactions 1. 447–455. 6 indexed citations
16.
Jones, Stuart, P. D. KENNEWELL, Robert Westwood, & Peter G. Sammes. (1990). A novel route to 1,2-benzothiazin-4-ones involving s-dealkylation of an arylalkyl sulphide. Journal of the Chemical Society Chemical Communications. 497–497. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026